Profile data is unavailable for this security.
About the company
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
- Revenue in USD (TTM)0.00
- Net income in USD-4.30m
- Incorporated2014
- Employees12.00
- LocationRegencell Bioscience Holdings Ltd11/F First Commercial Building33-35 Leighton Roa 999077Hong KongHKG
- Phone+852 21550823
- Websitehttps://www.regencellbioscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Beyondspring Inc | 1.88m | -15.57m | 68.91m | 35.00 | -- | -- | -- | 36.73 | -0.3987 | -0.3987 | 0.0481 | -0.749 | 0.0698 | -- | -- | 52,111.11 | -59.75 | -75.50 | -102.15 | -96.48 | -- | -- | -856.29 | -4,977.12 | -- | -- | -- | -- | 29.61 | -- | 36.82 | -- | -13.54 | -- |
| Citius Oncology Inc | 0.00 | 1.93m | 70.59m | -- | 4.09 | 0.1428 | 36.51 | -- | 0.242 | 0.242 | 0.00 | 6.93 | 0.00 | -- | -- | -- | 3.25 | -- | 3.35 | -- | -- | -- | -- | -- | -- | -- | 0.036 | -- | -- | -- | 535.30 | -- | -- | -- |
| Bioatla Inc | 11.00m | -81.82m | 71.55m | 65.00 | -- | 3.12 | -- | 6.50 | -1.70 | -1.70 | 0.2284 | 0.4751 | 0.103 | -- | -- | 169,230.80 | -76.61 | -48.72 | -103.22 | -57.35 | -- | -- | -743.79 | -6,651.71 | -- | -- | 0.00 | -- | -- | -- | -15.95 | -- | -37.01 | -- |
| Vistagen Therapeutics Inc | 875.70k | -39.57m | 72.67m | 45.00 | -- | 0.7595 | -- | 82.99 | -1.30 | -1.30 | 0.0289 | 3.44 | 0.0121 | -- | -- | 22,453.85 | -54.69 | -62.84 | -58.94 | -68.03 | -- | -- | -4,518.12 | -5,768.52 | -- | -- | 0.00 | -- | 568.10 | -- | 50.44 | -- | -18.91 | -- |
| P3 Health Partners Inc | 1.48bn | -102.69m | 72.90m | 400.00 | -- | 0.2739 | -- | 0.0494 | -0.753 | -0.753 | 11.08 | 0.744 | 1.71 | -- | 12.28 | 3,691,575.00 | -28.94 | -- | -83.29 | -- | -2.72 | 0.1781 | -16.95 | -56.93 | -- | -12.94 | 0.3358 | -- | 20.67 | 70.58 | 78.61 | -- | -11.20 | -- |
| Werewolf Therapeutics Inc | 3.39m | -62.12m | 73.08m | 45.00 | -- | 0.8022 | -- | 21.58 | -1.50 | -1.50 | 0.0819 | 2.04 | 0.0214 | -- | 1.06 | 72,042.55 | -39.26 | -- | -42.91 | -- | -- | -- | -1,834.55 | -- | -- | -- | 0.2228 | -- | 21.60 | -- | 30.56 | -- | -- | -- |
| Ovid Therapeutics Inc | 631.56k | -32.50m | 73.81m | 25.00 | -- | 0.968 | -- | 116.87 | -0.4598 | -0.4598 | 0.0089 | 1.07 | 0.0056 | -- | -- | 15,789.00 | -28.55 | -20.78 | -31.34 | -23.27 | -- | -- | -5,146.15 | -56.16 | -- | -- | 0.00 | -- | -73.93 | -- | 3.38 | -- | -17.14 | -- |
| Regencell Bioscience Holdings Ltd | 0.00 | -4.30m | 74.17m | 12.00 | -- | 9.02 | -- | -- | -0.3306 | -0.3306 | 0.00 | 0.6316 | 0.00 | -- | -- | 0.00 | -41.44 | -56.31 | -42.99 | -77.51 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 26.73 | -- | -- | -- |
| PDS Biotechnology Corp | 0.00 | -40.56m | 74.56m | 25.00 | -- | 3.39 | -- | -- | -1.17 | -1.17 | 0.00 | 0.5975 | 0.00 | -- | -- | 0.00 | -73.98 | -51.63 | -98.74 | -59.00 | -- | -- | -- | -- | -- | -19.13 | 0.5286 | -- | -- | -- | -5.11 | -- | -- | -- |
| VolitionRX Ltd | 1.29m | -29.87m | 74.60m | 110.00 | -- | -- | -- | 58.02 | -0.3623 | -0.3623 | 0.0155 | -0.2328 | 0.0837 | -- | 7.41 | 11,689.36 | -196.61 | -111.92 | -- | -196.20 | -- | -- | -2,348.71 | -10,793.31 | -- | -104.15 | -- | -- | 153.04 | -- | -16.68 | -- | 29.13 | -- |
| Armata Pharmaceuticals Inc | 5.47m | -41.36m | 75.62m | 66.00 | -- | -- | -- | 13.83 | -1.24 | -1.24 | 0.1312 | -1.41 | 0.0518 | -- | 1.02 | 82,833.34 | -39.21 | -59.78 | -116.66 | -72.70 | -- | -- | -756.59 | -1,113.72 | -- | -- | 1.90 | -- | -17.77 | -- | -87.03 | -- | 184.10 | -- |
| Aerovate Therapeutics Inc | 0.00 | -84.61m | 76.79m | 51.00 | -- | 0.954 | -- | -- | -2.99 | -2.99 | 0.00 | 2.79 | 0.00 | -- | -- | 0.00 | -72.99 | -- | -81.83 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -46.61 | -- | -- | -- |
| ESSA Pharma Inc | 0.00 | -27.67m | 76.79m | 50.00 | -- | 0.5957 | -- | -- | -0.6257 | -0.6257 | 0.00 | 2.90 | 0.00 | -- | -- | 0.00 | -19.33 | -23.01 | -19.81 | -23.67 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.27 | -- | -- | -- |
| Fibrobiologics Inc | 0.00 | -17.78m | 77.64m | 10.00 | -- | 27.76 | -- | -- | -0.8864 | -0.8864 | 0.00 | 0.0807 | 0.00 | -- | -- | 0.00 | -149.60 | -- | -225.38 | -- | -- | -- | -- | -- | -- | -- | 0.0403 | -- | -- | -- | -272.15 | -- | -- | -- |
| Chimerix Inc | 159.00k | -83.59m | 79.14m | 72.00 | -- | 0.5829 | -- | 497.76 | -0.9351 | -0.9351 | 0.0018 | 1.51 | 0.0008 | -- | 1.92 | 2,208.33 | -43.54 | -30.45 | -48.29 | -34.09 | 2.52 | -- | -52,574.84 | -442.93 | -- | -- | 0.00 | -- | -99.04 | -46.24 | -147.68 | -- | -13.24 | -- |
Data as of Nov 21 2024. Currency figures normalised to Regencell Bioscience Holdings Ltd's reporting currency: US Dollar USD
0.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Securities LLCas of 30 Sep 2024 | 17.88k | 0.14% |
| BlackRock Financial Management, Inc.as of 30 Sep 2024 | 238.00 | 0.00% |
| Qube Research & Technologies Ltd.as of 30 Sep 2024 | 0.00 | 0.00% |
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
